Adage Capital Partners Gp, L.L.C. Applied Therapeutics Inc. Transaction History
Adage Capital Partners Gp, L.L.C.
- $54.6 Billion
- Q3 2024
A detailed history of Adage Capital Partners Gp, L.L.C. transactions in Applied Therapeutics Inc. stock. As of the latest transaction made, Adage Capital Partners Gp, L.L.C. holds 4,112,361 shares of APLT stock, worth $2.8 Million. This represents 0.06% of its overall portfolio holdings.
Number of Shares
4,112,361
Previous 2,774,784
48.2%
Holding current value
$2.8 Million
Previous $13 Million
169.76%
% of portfolio
0.06%
Previous 0.02%
Shares
3 transactions
Others Institutions Holding APLT
# of Institutions
140Shares Held
112MCall Options Held
1.68MPut Options Held
1.91M-
Janus Henderson Group PLC London, X010.5MShares$7.17 Million0.05% of portfolio
-
Morgan Stanley New York, NY9.9MShares$6.74 Million0.01% of portfolio
-
Vr Adviser, LLC New York, NY9.83MShares$6.68 Million8.65% of portfolio
-
Perceptive Advisors LLC New York, NY8.01MShares$5.44 Million1.78% of portfolio
-
Franklin Resources Inc San Mateo, CA6.8MShares$4.62 Million0.02% of portfolio
About Applied Therapeutics Inc.
- Ticker APLT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 48,020,700
- Market Cap $32.7M
- Description
- Applied Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops novel products to target cardiovascular disease, galactosemia, and diabetic complications. Its lead product candidate is AT-007 that has completed phase 1/2 for the treatment of galactosemia in healthy volunteers and adults, as well as is in pediatric clinical study...